104 related articles for article (PubMed ID: 12185306)
1. Susceptibility of liver proliferative lesions in heterozygous p53 deficient CBA mice to various carcinogens.
Uehara T; Kashida Y; Watanabe T; Yasuhara K; Onodera H; Hirose M; Mitsumori K
J Vet Med Sci; 2002 Jul; 64(7):551-6. PubMed ID: 12185306
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular tumor induction in heterozygous p53-deficient CBA mice by a 26-week dietary administration of kojic acid.
Takizawa T; Mitsumori K; Tamura T; Nasu M; Ueda M; Imai T; Hirose M
Toxicol Sci; 2003 Jun; 73(2):287-93. PubMed ID: 12700405
[TBL] [Abstract][Full Text] [Related]
3. Lack of susceptibility of heterozygous p53-knockout CBA and CIEA mice to phenolphthalein in a 6-month carcinogenicity study.
Okamura M; Kashida Y; Watanabe T; Yasuhara K; Onodera H; Hirose M; Usui T; Tamaoki N; Mitsumori K
Toxicology; 2003 Mar; 185(1-2):17-22. PubMed ID: 12505441
[TBL] [Abstract][Full Text] [Related]
4. Modifying effects of ethinylestradiol but not methoxychlor on N-ethyl-N-nitrosourea-induced uterine carcinogenesis in heterozygous p53-deficient CBA mice.
Mitsumori K; Shimo T; Onodera H; Takagi H; Yasuhara K; Tamura T; Aoki Y; Nagata O; Hirose M
Toxicol Sci; 2000 Nov; 58(1):43-9. PubMed ID: 11053539
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the transgenic p53+/- mouse for detecting genotoxic liver carcinogens in a short-term bioassay.
Dass SB; Bucci TJ; Heflich RH; Casciano DA
Cancer Lett; 1999 Aug; 143(1):81-5. PubMed ID: 10465341
[TBL] [Abstract][Full Text] [Related]
6. Heterozygous p53-deficient mice are not susceptible to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) carcinogenicity.
Park CB; Kim DJ; Uehara N; Takasuka N; Hiroyasu BT; Tsuda H
Cancer Lett; 1999 May; 139(2):177-82. PubMed ID: 10395176
[TBL] [Abstract][Full Text] [Related]
7. Rapid induction of uterine tumors with p53 point mutations in heterozygous p53-deficient CBA mice given a single intraperitoneal administration of N-ethyl-N-nitrosourea.
Mitsumori K; Onodera H; Shimo T; Yasuhara K; Takagi H; Koujitani T; Hirose M; Maruyama C; Wakana S
Carcinogenesis; 2000 May; 21(5):1039-42. PubMed ID: 10783330
[TBL] [Abstract][Full Text] [Related]
8. Toxicology and carcinogenesis studies of o-nitrotoluene sulfone (CAS no. 88-72-2) in F344/N rats and B6C3F(1) mice (feed studies).
National Toxicology Program, Public Health Service, National Institutes of Health, US Department of Health and Human Services
Natl Toxicol Program Tech Rep Ser; 2002 May; (504):1-357. PubMed ID: 12087420
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent induction of aberrant crypt foci in the colons but no neoplastic lesions in the livers of heterozygous p53-deficient mice treated with low dose 2-amino-3-methylimidazo [4,5-f]quinoline.
Morimura K; Salim EI; Yamamoto S; Wanibuchi H; Fukushima S
Cancer Lett; 1999 Apr; 138(1-2):81-5. PubMed ID: 10378777
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
11. Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice.
Ward JM; Rice JM; Creasia D; Lynch P; Riggs C
Carcinogenesis; 1983 Aug; 4(8):1021-9. PubMed ID: 6872148
[TBL] [Abstract][Full Text] [Related]
12. Bioassay of mannitol and caprolactam and assessment of response to diethylnitrosamine in heterozygous p53-deficient (+/-) and wild type (+/+) mice.
Iatropoulos MJ; Jeffrey AM; Schlüter G; Enzmann HG; Williams GM
Arch Toxicol; 2001 Mar; 75(1):52-8. PubMed ID: 11357521
[TBL] [Abstract][Full Text] [Related]
13. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
[TBL] [Abstract][Full Text] [Related]
14. Phenolphthalein induces thymic lymphomas accompanied by loss of the p53 wild type allele in heterozygous p53-deficient (+/-) mice.
Dunnick JK; Hardisty JF; Herbert RA; Seely JC; Furedi-Machacek EM; Foley JF; Lacks GD; Stasiewicz S; French JE
Toxicol Pathol; 1997; 25(6):533-40. PubMed ID: 9437796
[TBL] [Abstract][Full Text] [Related]
15. Organ-dependent susceptibility of p53 knockout mice to 2-amino-3-methylimidazo[4,5-f]quinoline (IQ).
Hirata A; Tsukamoto T; Yamamoto M; Takasu S; Sakai H; Ban H; Yanai T; Masegi T; Donehower LA; Tatematsu M
Cancer Sci; 2007 Aug; 98(8):1164-73. PubMed ID: 17532756
[TBL] [Abstract][Full Text] [Related]
16. Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate and the effects of recovery.
David RM; Moore MR; Cifone MA; Finney DC; Guest D
Toxicol Sci; 1999 Aug; 50(2):195-205. PubMed ID: 10478855
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent.
French JE; Lacks GD; Trempus C; Dunnick JK; Foley J; Mahler J; Tice RR; Tennant RW
Carcinogenesis; 2001 Jan; 22(1):99-106. PubMed ID: 11159747
[TBL] [Abstract][Full Text] [Related]
19. Toxicology and carcinogenesis studies of milk thistle extract (CAS No. 84604-20-6) in F344/N rats and B6C3F1 mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2011 May; (565):1-177. PubMed ID: 21685957
[TBL] [Abstract][Full Text] [Related]
20. p53 knockout mice (-/-) are more susceptible than (+/-) or (+/+) mice to N-methyl-N-nitrosourea stomach carcinogenesis.
Yamamoto M; Tsukamoto T; Sakai H; Shirai N; Ohgaki H; Furihata C; Donehower LA; Yoshida K; Tatematsu M
Carcinogenesis; 2000 Oct; 21(10):1891-7. PubMed ID: 11023548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
